Integrated Wealth Management (Palm Desert)’s Pacira BioSciences PCRX Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,555	Closed	-$53K	–	787
2016 Q3	$53K	Hold	1,555	–	–	0.02%	401
2016 Q2	$52K	Buy	1,555 +25	+2%	+$1.23K	0.02%	398
2016 Q1	$81K	Hold	1,530	–	–	0.03%	312
2015 Q4	$117K	Hold	1,530	–	–	0.05%	264
2015 Q3	$63K	Hold	1,530	–	–	0.03%	338
2015 Q2	$108K	Hold	1,530	–	–	0.04%	270
2015 Q1	$135K	Buy	+1,530	New	+$155K	0.06%	241

Other funds holding PCRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s PCRX Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Pacira BioSciences (PCRX) in Q4 2016, closing a stake of 1,555 shares — an estimated $53K sold.

Integrated Wealth Management (Palm Desert) first reported a position in PCRX in Q1 2015 and held it in 7 quarters. The position peaked at $135K in Q1 2015. 182 funds tracked by Wall St. Rank hold PCRX as of Q4 2016.

Integrated Wealth Management (Palm Desert) reported no remaining Pacira BioSciences position as of Q4 2016 after selling out during the quarter.
Integrated Wealth Management (Palm Desert) sold 1,555 Pacira BioSciences shares in Q4 2016, an estimated $53K.
Integrated Wealth Management (Palm Desert) first reported a position in Pacira BioSciences in Q1 2015 and held it in 7 quarters.
Integrated Wealth Management (Palm Desert)'s Pacira BioSciences position peaked at $135K in Q1 2015.
182 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.